MRNA Jan 2023 115.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.9600

-0.1000

(-9.43%)

At close: 03:30PM EST

Simply Wall St.
44%of this Moderna, Inc. (NASDAQ:MRNA) insider's holdings were sold in the last year
Looking at Moderna, Inc.'s ( NASDAQ:MRNA ) insider transactions over the last year, we can see that insiders were net...
Motley Fool
Moderna Stock: Buy, Sell, or Hold in 2023?
Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.
Zacks
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.